Literature DB >> 22868858

In the clinic. Lyme disease.

Linden T Hu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22868858     DOI： 10.7326/0003-4819-157-3-201208070-01002

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

1.  Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question.

Authors:  Jinoos Yazdany; Gabriela Schmajuk; Mark Robbins; David Daikh; Ashley Beall; Edward Yelin; Jennifer Barton; Adam Carlson; Mary Margaretten; Joann Zell; Lianne S Gensler; Victoria Kelly; Kenneth Saag; Charles King
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

2.  Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.

Authors:  Melanie Uhde; Mary Ajamian; Xueting Li; Gary P Wormser; Adriana Marques; Armin Alaedini
Journal:  Clin Infect Dis       Date:  2016-09-01       Impact factor: 9.079

Review 3.  Brave New Worlds: The Expanding Universe of Lyme Disease.

Authors:  Brandee L Stone; Yvonne Tourand; Catherine A Brissette
Journal:  Vector Borne Zoonotic Dis       Date:  2017-07-20       Impact factor: 2.133

4.  Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.

Authors:  Elzbieta Jacek; Kevin S Tang; Lars Komorowski; Mary Ajamian; Christian Probst; Brian Stevenson; Gary P Wormser; Adriana R Marques; Armin Alaedini
Journal:  J Immunol       Date:  2015-12-30       Impact factor: 5.422

5.  [Diagnosis and treatment of Lyme arthritis. Recommendations of the Pharmacotherapy Commission of the Deutsche Gesellschaft für Rheumatologie (German Society for Rheumatology)].

Authors:  M Gaubitz; F Dressler; H I Huppertz; A Krause
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

6.  Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.

Authors:  Bijaya Sharma; Autumn V Brown; Nicole E Matluck; Linden T Hu; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

7.  Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of Lyme disease but not posttreatment Lyme disease syndrome.

Authors:  Kevin S Tang; Mark S Klempner; Gary P Wormser; Adriana R Marques; Armin Alaedini
Journal:  Clin Infect Dis       Date:  2015-07-28       Impact factor: 9.079

8.  Erythema migrans associated with partial Horner's syndrome.

Authors:  Isha Verma; Abhinav Agrawal
Journal:  BMJ Case Rep       Date:  2015-12-07

9.  Lyme disease: case report of persistent Lyme disease from Pulaski County, Virginia.

Authors:  James R Palmieri; Scott King; Matthew Case; Arben Santo
Journal:  Int Med Case Rep J       Date:  2013-12-05

10.  BB0347, from the lyme disease spirochete Borrelia burgdorferi, is surface exposed and interacts with the CS1 heparin-binding domain of human fibronectin.

Authors:  Robert A Gaultney; Tammy Gonzalez; Angela M Floden; Catherine A Brissette
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.